| Primary |
| Hormone Replacement Therapy |
38.1% |
| Product Used For Unknown Indication |
23.1% |
| Menopausal Symptoms |
8.8% |
| Ill-defined Disorder |
6.8% |
| Oestrogen Replacement Therapy |
6.2% |
| Prenatal Care |
1.9% |
| Progesterone Decreased |
1.9% |
| Drug Use For Unknown Indication |
1.6% |
| Menopause |
1.6% |
| Hormone Therapy |
1.2% |
| In Vitro Fertilisation |
1.2% |
| Hypertension |
1.0% |
| Hypothyroidism |
1.0% |
| Menstruation Irregular |
1.0% |
| Pregnancy |
1.0% |
| Infertility Female |
0.8% |
| Vitamin Supplementation |
0.8% |
| Amenorrhoea |
0.7% |
| Anxiety |
0.7% |
| Menstrual Disorder |
0.7% |
|
| Breast Cancer |
38.0% |
| Off Label Use |
13.3% |
| Abortion Spontaneous |
9.6% |
| Insomnia |
3.6% |
| Vaginal Haemorrhage |
3.0% |
| Vision Blurred |
3.0% |
| Vomiting |
3.0% |
| Cerebrovascular Accident |
2.4% |
| Incorrect Route Of Drug Administration |
2.4% |
| Loss Of Consciousness |
2.4% |
| Somnolence |
2.4% |
| Transient Ischaemic Attack |
2.4% |
| Breast Cancer In Situ |
1.8% |
| Dizziness |
1.8% |
| Drug Effect Decreased |
1.8% |
| Drug Interaction |
1.8% |
| Ectopic Pregnancy |
1.8% |
| Fatigue |
1.8% |
| Headache |
1.8% |
| Hypersensitivity |
1.8% |
|
| Secondary |
| Hormone Replacement Therapy |
56.8% |
| Menopause |
11.9% |
| Menopausal Symptoms |
7.7% |
| Product Used For Unknown Indication |
4.2% |
| Foetal Exposure During Pregnancy |
2.9% |
| Drug Use For Unknown Indication |
2.5% |
| Depression |
2.2% |
| Hot Flush |
2.1% |
| Hypertension |
1.6% |
| Rickets |
1.0% |
| Bipolar Disorder |
0.9% |
| Osteopenia |
0.9% |
| Anxiety |
0.9% |
| Hypothyroidism |
0.9% |
| Insomnia |
0.8% |
| Hormone Therapy |
0.7% |
| Maternal Exposure Timing Unspecified |
0.6% |
| Oestrogen Replacement Therapy |
0.6% |
| Asthma |
0.5% |
| Back Pain |
0.5% |
|
| Breast Cancer |
39.7% |
| Breast Cancer Female |
25.4% |
| Breast Cancer Metastatic |
10.4% |
| Breast Cancer In Situ |
2.4% |
| Progesterone Receptor Assay Positive |
1.9% |
| Vaginal Haemorrhage |
1.9% |
| Breast Cancer Recurrent |
1.7% |
| Ovarian Cancer |
1.7% |
| Uterine Leiomyoma |
1.7% |
| Off Label Use |
1.6% |
| Ovarian Cancer Metastatic |
1.6% |
| Vulvovaginal Discomfort |
1.4% |
| Breast Disorder |
1.2% |
| Deep Vein Thrombosis |
1.2% |
| Memory Impairment |
1.2% |
| Endometrial Cancer Stage I |
1.0% |
| Tricuspid Valve Incompetence |
1.0% |
| Ultrasound Breast Abnormal |
1.0% |
| Abortion Spontaneous |
0.9% |
| Loss Of Consciousness |
0.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.7% |
| Drug Use For Unknown Indication |
14.8% |
| Hypertension |
7.5% |
| Asthma |
7.4% |
| Hormone Replacement Therapy |
6.7% |
| Depression |
5.4% |
| Pain |
4.1% |
| Rheumatoid Arthritis |
4.0% |
| Menopause |
3.8% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Hypothyroidism |
3.3% |
| Anxiety |
2.8% |
| Fibromyalgia |
2.4% |
| Insomnia |
2.3% |
| Blood Cholesterol Increased |
2.2% |
| Osteoporosis |
2.1% |
| Diabetes Mellitus |
2.1% |
| Restless Legs Syndrome |
2.0% |
| Prophylaxis |
1.9% |
| Migraine |
1.9% |
|
| Weight Increased |
12.0% |
| Nausea |
8.9% |
| Vision Blurred |
6.8% |
| Rash |
6.5% |
| Weight Decreased |
6.5% |
| Vomiting |
6.2% |
| Drug Ineffective |
4.8% |
| Vaginal Haemorrhage |
4.8% |
| Pain In Extremity |
4.5% |
| Paraesthesia |
4.1% |
| Suicidal Ideation |
4.1% |
| Wound Drainage |
4.1% |
| Throat Tightness |
3.8% |
| Tinnitus |
3.8% |
| Fatigue |
3.4% |
| Flushing |
3.4% |
| Tremor |
3.4% |
| Ventricular Septal Defect |
3.4% |
| Dyspnoea |
2.7% |
| Headache |
2.7% |
|
| Interacting |
| Menopausal Symptoms |
42.9% |
| Bipolar Disorder |
21.4% |
| Hormone Replacement Therapy |
14.3% |
| Depression |
7.1% |
| Hot Flush |
7.1% |
| Prevention Of Endometrial Hyperplasia |
7.1% |
|
| Drug Interaction |
80.0% |
| Loss Of Consciousness |
20.0% |
|
